Darbepoietin is very similar to Amgen's product for chemotherapy patients, Procrit.
It is supposedly made to address anemia in Kidney dialysis patients rather than cancer patients. How anemia, and stimulating the production of RBC's, in each case differs is beyond me right now. Along the same lines, I recently saw a "corporate summary" for Amgen in our local newspaper. It stated in no uncertain terms that Amgen had fully developed EPO "by 1983". It made no mention of when it was available as a prescription drug (I was under the impression that it was 1989). This is much earlier than I have ever seen in anything I have read. /Brian McEwen -----Original Message----- From: Philip Weishaar [mailto:[EMAIL PROTECTED]] Sent: Tuesday, February 26, 2002 10:42 AM To: track list Subject: t-and-f: Olympic DQ's In some ways I hate to bring this up but I am surprised noone has mentioned the 3 DQ's Sunday in Salt Lake for the using the newest version of EPO called darpopeitin (sorry about the spelling). Chemical just released and isn't even on the list of banned substances yet but certainly will be. What was interesting was that athletes who were DQ'ed were only DQ'ed for Saturday and Sunday's events. Earlier tests were negative so those events stood. The testers must be catching up with the users at least for a little while. phil weishaar
